Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT

Search results

• Finished

  A multicentre, randomised, double blind, placebo-controlled, parallel group trial of the effectiveness of the nocturnal use of a Temperature Controlled Laminar Airflow (TLA) device (Protexo®) in adults with poorly-controlled, severe allergic asthma: the LASER trial

  Fogg, C., Dewey, A., Dean, T. & Chauhan, A.

  Portsmouth Hospitals University NHS Trust

  1/12/13 → 31/05/17

  Project: Research

  • asthma 100%
  • devices 78%
  • Airflow 60%
  • air flow 60%
  • Placebo 58%